Autopsy report · NCT00003492

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

“Slow accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 7 months after it had already started.
• Ran for about 4 years 8 months before it stopped.
• 9 participants enrolled.
• Results were posted on the registry 20 years after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Burzynski Research Institute

Sponsor type

University, hospital or other

Conditions

Stage IV Lung Cancer

Interventions

Antineoplaston therapy (Atengenal + Astugenal)

Participants

9

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.